This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of Michigan. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Innovations in Cancer Treatment by Mats Ljungman
Introduction
Mats Ljungman is a prominent inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of cancer research through his innovative work. His research focuses on therapeutic targets for cancer, particularly in the development of small molecules and nucleic acids.
Latest Patents
Mats Ljungman holds a patent for "Compositions and methods for treating cancer." This invention relates to therapeutic targets for cancer, specifically targeting ATDC (TRIM29) expression in cases of cancer with ATDC overexpression. He has 1 patent that showcases his commitment to advancing cancer treatment.
Career Highlights
Mats Ljungman is affiliated with the University of Michigan, where he conducts his research. His work has been instrumental in exploring new avenues for cancer therapy, contributing to the scientific community's understanding of cancer treatment.
Collaborations
Mats has collaborated with notable colleagues, including Diane M Simeone and Liang Xin Xu. These partnerships have enhanced his research efforts and broadened the impact of his work in the field of cancer treatment.
Conclusion
Mats Ljungman's innovative contributions to cancer research highlight the importance of targeted therapies in treating this complex disease. His work continues to inspire advancements in medical science and offers hope for improved cancer treatments in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile